NSE filing, NSE: LXCHEM. Summary written from the filing by ALFA Finder's alert engine.
Laxmi Organic Industries Ltd: key numbers
- Share price
- ₹154.83
- Market cap
- ₹4,303 Cr
- Revenue (annual)
- ₹2,847 Cr
- Net profit (annual)
- ₹79.36 Cr
- P/E (TTM)
- 34.2×Sector 34.1×
- Promoter holding
- 69.16%-0.18% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi Organic Industries Ltd
All →Laxmi Organic Industries Board Meeting Date
Laxmi Organic Industries intimated that its Board will meet on 05/11/2026 to consider unaudited financial results for Q1 and H1 FY27. No material decision has been reported yet.
Laxmi Organic Industries Other Announcement
Laxmi Organic Industries Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, pursuant to SEBI regulations.
Laxmi Organic Industries Management Change
Laxmi Organic Industries announced the resignation of Dr. Rajan Venkatesh as MD & CEO and the appointment of Mr. Harshvardhan Goenka as his successor, effective November 2026.
Laxmi Organic Industries Management Change
Laxmi Organic Industries announced the resignations of Chief Procurement Officer Dr. Keshav Ruthia and Chief Technology Officer Mr. Salil Mukundan, effective October 31, 2026.
Laxmi Organic Industries Annual General Meeting
Laxmi Organic Industries Limited held its 37th Annual General Meeting on August 5, 2026. Key items included adoption of financial results, dividend declaration, and director appointments.
Laxmi Organic Industries Investor Presentation: Key Takeaways
Laxmi Organic reported strong Q1 FY27 results with 40% YoY revenue growth to INR 9,683 Mn and 216% PAT growth. Margin expansion was driven by volume, pricing, and operating leverage.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.